文献速递主动脉疾病外周动脉疾病

腹主动脉瘤患者皮肤晚期糖基化终末产物蓄积增加

Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2017-06-24

一项病例对照研究纳入248例AAA患者和124例无AAA或PAD的年龄、糖尿病状态匹配对照,用皮肤自发荧光(SAF)无创评估晚期糖基化终末产物(AGEs)蓄积。校正心血管共病后SAF每升高1单位与AAA存在的调整OR为1.78(95%CI 1.22-2.60),但进一步校正性别、吸烟、高血压和降脂药后显著性丧失(调整OR 1.53,95%CI 0.94-2.48)。

要点

  • AAA患者皮肤AGEs蓄积(SAF)高于无AAA或PAD的匹配对照。
  • AAA患者中合并PAD与SAF升高独立相关。
  • SAF与AAA的关联在校正吸烟、高血压和降脂药后不再显著。

核心结论

  • AAA患者皮肤AGEs蓄积(SAF)较无AAA或PAD的对照增加,独立于冠状动脉疾病和脑血管疾病的存在。
  • AAA患者中SAF与PAD及心血管危险因素密切相关。

研究设计与样本

  • 病例对照研究,纳入248例AAA患者和124例无AAA或PAD的对照,按年龄和糖尿病状态匹配。
  • 使用AGE Reader无创评估皮肤自发荧光(SAF)。

主要发现

  • 全队列logistic回归:SAF每升高1单位,AAA存在的未调整OR为1.74(95%CI 1.20-2.51),校正脑血管病和冠心病后调整OR为1.78(95%CI 1.22-2.60)。
  • 进一步校正性别、当前吸烟、高血压和降脂药使用后,SAF与AAA的关联失去显著性(调整OR 1.53,95%CI 0.94-2.48)。

临床怎么用

  • SAF可作为AAA患者心血管危险因素负荷和合并PAD的无创评估指标。
  • SAF与AAA的独立关联在充分校正生活方式和药物后减弱,解读时需考虑混杂因素。

局限性

  • 病例对照设计不能推断因果关系。
  • SAF与AAA的关联在进一步校正性别、吸烟、高血压和降脂药后不再显著,提示残余混杂可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Advanced glycation end products (AGEs) are implicated in the pathogenesis of cardiovascular disease. Accumulation of AGEs is driven by oxidative or glycemic stress and can be assessed by skin autofluorescence (SAF). SAF is increased in patients with peripheral artery disease (PAD) and independently associated with mortality and major adverse cardiovascular events in these patients. PAD and abdominal aortic aneurysm (AAA) share several risk factors. Inflammation is an important process in AAA formation and increases levels of oxidative stress. We therefore hypothesized that SAF would be increased in AAA patients compared with controls. METHODS: A case-control study was performed in 248 AAA patients and 124 controls without AAA or PAD matched for age and presence of diabetes mellitus. SAF was noninvasively assessed with the AGE Reader (Diagnoptics Technologies BV, Groningen, The Netherlands). RESULTS: SAF was higher in AAA patients than in controls: 2.89 ± 0.63 vs 2.68 ± 0.63 arbitrary units (P = .003). PAD comorbidity was associated with increased SAF within the AAA patient group (P = .01). After correction for known factors influencing SAF (age, current smoking, hypertension, and estimated glomerular filtration rate), PAD comorbidity remained an independent determinant of SAF. Logistic regression analysis of the total cohort showed an unadjusted odds ratio (OR) of 1.74 (95% confidence interval [CI], 1.20-2.51) for the presence of AAA with each unit increase of SAF and an adjusted OR of 1.78 (95% CI, 1.22-2.60) after correction for cardiovascular comorbidity (cerebrovascular disease and coronary artery disease). After additional correction for sex, current smoking, hypertension, and use of lipid-lowering drugs, this significance was lost (adjusted OR, 1.53; 95% CI, 0.94-2.48). CONCLUSIONS: Skin accumulation of AGEs, measured by SAF, is increased in patients with AAA compared with controls without AAA or PAD, independent of the presence of coronary artery disease and cerebrovascular disease. In AAA patients, SAF is closely associated with the presence of PAD and cardiovascular risk factors.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Boersema J, de Vos LC, Links TP, et al. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg. 2017. PMID: 28655550. doi:10.1016/j.jvs.2017.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。